Why Genetic Consistency is the Quiet Key to Predictable R&D
Every biotech company wants speed. Faster discovery, faster validation, faster movement toward commercialization. Yet many of the most expensive delays in R&D have nothing to do with ambition or effort. They come from inconsistency. Results that cannot be replicated. Data that looks promising in one lab but unravels in another. Processes that behave differently at…

